In individuals with T2DM, there is a reduction in the quantity of anti-inflammatory T-cell subsets, such as regulatory T-cells (Treg), M2-like macrophages, and IgM-producing B-1 cells, alongside an elevation in the number and/or ratio of inflammatory effector T-cells (36). This evidence concerns the gene CD40LG and type 2 diabetes mellitus.